Tafsure

Tenofovir Alafenamide 25 mg

Send Enquiry



Description

Description

Tafsure 25

Composition: Tenofovir Alafenamide – 25 mg

Therapeutic Class: Antiviral

Tafsure: Chosen for Hepatitis B Control

Tafsure is a widely prescribed hepatitis B medicine, which is highly effective against Hepatitis B virus.

Aprazer Healthcare: Trusted worldwide for Hepatitis B medicine

Aprazer Healthcare, pioneering innovative treatments for Hepatitis B, is the largest Hepatitis medicine Manufacturer.

  • • WHO- GMP certified, assured therapeutic efficacy and quality.
  • • Aprazer Healthcare products are available worldwide in 20+ countries.

What is Tafsure?

Tafsure is an antiretroviral medicine used against HBV and HIV-1 infection.

Uses of Tafsure

  • • Chronic Hepatitis B
  • • HIV-1 infections

How does Tafsure work?

  • • It is incorporated as a prodrug, which gets phosphorylated to the active form.
  • • Inhibits the reverse transcriptase enzyme.
  • • Inhibits virus replication
  • • Causes cell death

Benefits

  • • Reduces viral load
  • • Improves liver functions
  • • It can be used in both compensated and decompensated liver disease.
  • • Fewer side-effects
  • • Potent targeted effect

Common Side Effects

  • • Nausea
  • • Dizziness
  • • Headache
  • • Digestive issues
  • • Tiredness
  • • Diarrhea

Serious Side Effects

  • • Lactic Acidosis – unusual pain, breathing issues, irregular heartbeats, abdominal pain
  • • Irregular heartbeat
  • • Trouble breathing
  • • Enlarged fatty liver

Precautions

To be cautiously used in patients with:

  • • Kidney disorders
  • • HIV – co-infections
  • • Liver transplant
  • • Elderly patients

Contraindication

  • • Not to be used if any previous allergy or hypersensitivity to tenovofir or any excipients.
  • • Breastfeeding mothers
  • • Pregnant women
  • • It cannot be used as a single therapy for HIV patients

Warning

To be used under medical prescription only

Important Safety and Monitoring Information

Regular monitoring of the liver function, renal function, and bone density. Screen for viral load and HIV infections before treatment initiation.

Download Product PDF Attachment